Trial | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | Score |
|---|
Wang et al | ✓ | ✓ | ✓ | ✓ | x | x | ✓ | ✓ | x | ✓ | ✓ | 7/10 |
Yuenyongviwat et al | ✓ | ✓ | ✓ | ✓ | x | x | x | ✓ | ✓ | ✓ | ✓ | 7/10 |
Singh et al | ✓ | ✓ | x | ✓ | x | x | ✓ | ✓ | x | ✓ | ✓ | 6/10 |
Bennell et al | ✓ | ✓ | ✓ | ✓ | x | x | ✓ | ✓ | ✓ | ✓ | ✓ | 8/10 |
Jorge et al | ✓ | ✓ | ✓ | ✓ | x | x | ✓ | ✓ | ✓ | ✓ | ✓ | 8/10 |
Elizabeth A. Sled | ✓ | x | x | ✓ | x | x | x | ✓ | ✓ | ✓ | ✓ | 5/10 |
Chaudhary Ashok | ✓ | ✓ | x | ✓ | x | x | x | x | x | x | ✓ | 3/10 |
- Items for methodological quality criteria (2–11 were considered for total score):
- 1: Were the eligibility criteria specified?
- 2: Were subjects randomly allocated to groups?
- 3: Was allocation concealed?
- 4: Were groups similar at baseline for the most important prognostic indicators?
- 5: Were all subjects blinded?
- 6: Were all therapists who administered therapy blinded?
- 7: Were all assessors who measured at least one key outcome blinded?
- 8: Were measures of at least one key outcome obtained from > 85% of the subjects initially allocated to groups?
- 9: Did all subjects (for whom outcome measures were available) receive the treatment or control condition as allocated, or, where this was not the case, was data for a least one key outcome analyzed by intention to treat?
- 10: Were the results of between-group statistical comparisons reported for at least one key outcome?
- 11: Did the study provide both point measures and measures of variability for at least one key outcome?
